 3. Patient has anticipated or potential sources of emboli e.g. known previously symptomatic patent foramen ovale PFO, mechanical heart valve, or deep vein thrombosis DVT treated within 6 months that are not adequately treated with anticoagulants for at least two weeks with documented coagulation parameters in the target therapeutic range. 